Two To The Dozen

Posted on: 04 April 2008 by Gareth Hargreaves

The largest ever European wide study has found that one in six men suffer from erectile dysfunction.

The largest ever European wide study has found that one in six men suffer from erectile dysfunction.

The largest ever study assessing Men’s Attitudes to Life Events and Sexuality (MALES), published in the latest issue of Current Medical and Research Opinion shows that almost one in six (16%) of the general male population aged 20 to 75 experience erectile dysfunction (ED).

The results are consistent with other reports that estimate that some degree of erectile dysfunction affects more than half of men over the age of 40, and that worldwide an estimated 152 million men suffer from the condition. Defined as the consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance, experts predict that the number of men suffering from ED will double to 322 million by 2025.

The MALES study is one of the largest surveys to investigate prevalence of ED ever undertaken. Unfortunately, ED is still a condition that remains under diagnosed despite the many medical risk factors associated with it. Men with other medical conditions such as cardiovascular disease, hypertension, dyslipidemia, and depression have a higher diagnosis than ED. Overall 29% of the men with ED also reported one another medical condition, 20% reported two, 11% reported three, and 5% reported four or more.

The study also showed that among the men who reported ED, less than six out of 10 (58%) sought professional help for their condition. Of those that did, only half were prescribed an oral therapy, and only 16 percent of men with ED were maintaining treatment with the only oral therapy available at the time the study was undertaken. The study also showed that reliability and rapid onset are two of the key parameters men are looking for when considering treatment options, while lack of effect was cited by 34 percent of patients who discontinued treatment.

In total 27,839 men aged between 20 and 75 from across Europe, were questioned for the study.

Share with friends



Rating:

You need to be signed in to rate.